Revvity stock gains on RBCs 135 dollar call
Published on 09/01/2026 at 21:15 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Revvity Inc. (US76155R1086) stock drew fresh attention on September 1, 2026, after RBC Capital started coverage with a Sector Perform rating and a USD 135 price target. The same update put the share price at USD 128.67, near the 52-week high of USD 130.07.
RBC frames the move
According to the RBC coverage report on Investing.com, the bank sees durable diagnostics and life sciences franchises, but it also points to a 6 percent to 8 percent long-term organic growth outlook and slower growth in two units. That combination matters because the valuation debate now sits next to a stock that had already risen 31 percent over the past six months.
The stock was quoted at USD 128.67 in the same report, while Yahoo Finance showed a market capitalization of USD 14.47 billion, a 52-week range of USD 97.32 to USD 129.50, and trailing revenue of USD 2.72 billion as of September 1, 2026.
Quarterly numbers stay relevant
Investing.com also said Revvity reported second-quarter adjusted EPS of USD 1.41 and revenue of USD 729.68 million, both above Wall Street expectations of USD 1.21 and USD 703.39 million. The earnings beat was tied to USD 16 million in tariff refunds and tax savings.
For investors, that mix is the key tension: a near-high share price on one side, and a second-quarter beat with USD 1.41 in adjusted EPS on the other. The market is now weighing whether the 6 percent to 8 percent organic growth view can hold against slowing segments.
Revvity diagnostics and life sciences
Revvity sells diagnostics and lab tools, and the latest coverage puts that mix back at the center of the valuation debate.
Diagnostics and tools
Revvity said it generated revenue of USD 729.68 million in the second quarter and adjusted EPS of USD 1.41, which gave the market a concrete benchmark for the current run rate. Against that backdrop, the USD 135 price target now sits above the latest quoted price by USD 6.33.
Revvity stock at a glance
Revvity stock traded at USD 128.67 on September 1, 2026, with a market capitalization of USD 14.47 billion and a 52-week range of USD 97.32 to USD 129.50. The latest quote places the share only USD 0.83 below the top of that range.
Revvity fact box
- Company: Revvity Inc.
- ISIN: US76155R1086
- Ticker: RVTY
- Trading venue: NYSE
- Price (as of September 1, 2026): USD 128.67
- Market capitalization: USD 14.47 billion (as of September 1, 2026)
- Sector / Industry: Healthcare / Diagnostics & Research
- Index membership: S&P 500
